Drugs / Toronto association
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05052879 | Jul 2024 → May 2026 overdue | erectile dysfunction, premature ejaculation | EMS | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Toronto association | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05052879 ↗ |
| Route | Oral | “Toronto association coated tablet, 20 mg + 30 mg or 20 mg + 60 mg, oral, 2 hours before the sexual intercourse.” NCT05052879 ↗ |